Related Experiment Videos

Rational drug design: mirage or miracle?

Canadian Medical Association Journal

|October 17, 1970

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Agonist and antagonist opioid activity of axial and equatorial conformations of S-methyl- and S-allyl-morphinans.

European journal of pharmacology·1994

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog.

Antimicrobial agents and chemotherapy·1991

Neurobehavioral evidence for kappa agonist activity of the morphinan derivative 14-beta-methyl 8-oxacyclorphan [BC (3016)].

Pharmacology, biochemistry, and behavior·1991

Some remarkable effects of thiopeptide and derived linkages on lysozyme release from neutrophils by esters of the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe-OR).

International journal of immunopharmacology·1989

14-beta-Methyl-8-oxacyclorphan (BC-3016), a morphinan derivative with high affinity for kappa opioid receptor: comparison with dynorphin-A(1-13).

Canadian journal of physiology and pharmacology·1986

Cyclic tetrameric clusters of chemotactic peptides as superactive activators of lysozyme release from human neutrophils.

Biochemical and biophysical research communications·1984

See all related articles